Auxilium On a Roll ...
Health Care: Drugs
Allergan Inc. (AGN: NYSE)
$88.58 0.49 | 0.56%
06/04/12 - 04:02 PM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 5.42B | 4.92B | 4.50B | 4.40B |
| Cost of Sales | 614.50M | 575.80M | 608.90M | 645.20M |
| Gross Operating Profit | 4.80B | 4.34B | 3.89B | 3.76B |
| Selling, General, and Administrative Expenses | 2.25B | 2.63B | 1.92B | 1.86B |
| Research & Development | 902.80M | 804.60M | 706.00M | 797.90M |
| Operating Income before D & A (EBITDA) | 1.66B | 912.20M | 1.27B | 1.10B |
| Depreciation & Amortization | 261.80M | 284.20M | 288.30M | 266.90M |
| Interest Income | 6.90M | 7.30M | 7.00M | 33.50M |
| Other Income - Net | -500.00K | -16.40M | -9.60M | 18.20M |
| Special Income / Charges | -23.70M | -369.10M | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | 1.37B | 249.50M | 925.40M | 847.80M |
| Interest Expense | 71.80M | 78.70M | 76.90M | 60.60M |
| Pre-Tax Income | 1.30B | 170.80M | 848.50M | 787.20M |
| Income Taxes | 361.60M | 165.90M | 224.70M | 207.00M |
| Minority Interest | 3.60M | 4.30M | 2.50M | 1.60M |
| Net Income From Continuing Operations | 934.50M | 600.00K | 623.80M | 578.60M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | 934.50M | 600.00K | 623.80M | 578.60M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | 934.50M | 600.00K | 621.30M | 578.60M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
962.80M | 370.00M | 674.70M | 619.90M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | 934.50M | 600.00K | 623.80M | 578.60M |
| Basic EPS from Continuing Ops. | 3.07 | 0.00 | 2.05 | 1.90 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | 3.07 | 0.00 | 2.05 | 1.90 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | 3.07 | 0.00 | 2.05 | 1.90 |
| Basic Normalized Net Income/Share | 3.16 | n.a. | 2.22 | 2.04 |
| EPS fr Continuing Ops. | 3.01 | 0.00 | 2.03 | 1.89 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | 3.01 | 0.00 | 2.03 | 1.89 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | 3.01 | 0.00 | 2.03 | 1.89 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
3.10 | n.a. | 2.20 | 2.02 |
| Dividends Paid per Share | 0.20 | 0.20 | 0.20 | 0.20 |
Portfolios with AGN
- Portfolio NameUser Type
- UserOil/Gas Feb 2012
- Contributor7 Stocks Set To Rise at Lea...
- UserCLUBCAR47 Portfolio 1
- UserLes's Picks
- ProBridger Management
- ContributorTop 20 Stocks With Large Se...
- ContributorRocket Stocks for the Week ...
- Contributor10 Pharmaceutical Stocks Wi...
- ContributorCramer's Openings in Health...
- ContributorCramer's Vice and Vanity St...
Latest AGN Headlines from TheStreet
- Allergan Stock To Go Ex-dividend Tomorrow (AGN) 05.21.12 | 09:05 am
- Ex-Dividend Stocks: Thomson Reuters, Infosys 05.21.12 | 05:05 am
- Cramer's 'Mad Money' Recap: 7 Stocks to Scoop Up When On Sale 05.09.12 | 08:05 pm
- Allergan Inc. (AGN): Today's Featured Drugs Winner 05.03.12 | 05:05 pm
- Allergan Management Discusses Q1 2012 Results - Earnings Call Transcript 05.02.12 | 04:05 pm
- 3 Stocks I Saw on TV, May 2
05.02.12 | 08:05 am - The Week Ahead: Jobs Data; Earnings from MasterCard, Visa, Whole Foods 04.29.12 | 06:04 pm
- Allergan Stock Hits New 52-Week High (AGN) 04.26.12 | 01:04 pm
- 3 Stocks I Saw on TV, April 13 04.13.12 | 08:04 am
- Cramer's 'Mad Money' Recap: Love and Hip Stocks (Final) 04.12.12 | 06:04 pm
Press Releases for AGN
- Allergan Reports First Quarter 2012 Operating Results - Business Wire 05.02.12 | 09:05 am
- BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary Of U.S. Food And Drug Administration Approval - Business Wire 04.13.12 | 09:04 am
- Allergan Announces Quarterly Conference Call - Business Wire 04.06.12 | 01:04 pm
- Allergan Announces Positive Top-Line Results From Phase III BOTOX® Overactive Bladder Program - Business Wire 03.28.12 | 09:03 am
- U.S. Federal Court Finds In Favor Of Allergan, Inc. And Issues Permanent Injunction Against Merz Pharmaceuticals And Merz Aesthetics - Business Wire 03.12.12 | 09:03 am
- Allergan Announces Research & Development Technology Review - Business Wire 02.15.12 | 04:02 pm
- Allergan Reports Fourth Quarter 2011 Operating Results - Business Wire 02.02.12 | 09:02 am
- Allergan Announces Quarterly Conference Call - Business Wire 01.06.12 | 06:01 pm
- Actress Christina Hendricks Urges Women To Join Her In The Final Weeks Of The LATISSE® Wishes Challenge To Increase Money Raised For The Make-A-Wish Foundation® From $390,000 To Campaign Goal Of $500,000 - PR Newswire 11.09.11 | 08:11 am
- Allergan Reports Third Quarter 2011 Operating Results - Business Wire 10.26.11 | 09:10 am
Partner Headlines for AGN
- Time To Take Another Look At The Biotechnology Sector - Seeking Alpha 04.09.12 | 09:04 am
- Cracker Barrel and Other Stocks Insiders Are Buying - Benzinga 04.06.12 | 06:04 am
- Court Deals Blow to Botox Competitor - Analyst Blog - Zacks 03.16.12 | 05:03 pm
- MAP Pharma: Making Money From Migraines - Seeking Alpha 03.11.12 | 09:03 am
- Cramer's Mad Money - 15 Things To Watch This Week (1/27/12) - Seeking Alpha 01.29.12 | 07:01 am
- 6 Drug Companies Favored By Hedge Funds - Seeking Alpha 01.05.12 | 09:01 am
- ETF Showdown: Fun With Pharma - Benzinga 12.30.11 | 04:12 pm
- A Look At Atalanta Sosnoff Capital's Top Buys - Seeking Alpha 11.17.11 | 08:11 am
- Medicis Misses Zacks Consensus - Analyst Blog - Zacks 11.11.11 | 10:11 am
- A Look at The New DRGS ETN - Benzinga 10.31.11 | 01:10 pm
